These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30121056)

  • 1. Octreotide ameliorates dermal fibrosis in bleomycin-induced scleroderma.
    Oyucu Orhan S; Tektemur A; Gözel N; Özercan İH; Yolbaş S; Yıldırım A; Önalan E; Koca SS
    Turk J Med Sci; 2018 Aug; 48(4):886-891. PubMed ID: 30121056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin prevents the development of dermal fibrosis in bleomycin-induced scleroderma.
    Koca SS; Ozgen M; Sarikaya M; Dagli F; Ustundag B; Isik A
    Clin Exp Dermatol; 2014 Mar; 39(2):176-81. PubMed ID: 24033834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibition prevents development of experimental dermal fibrosis.
    Koca SS; Ozgen M; Dagli F; Tuzcu M; Ozercan IH; Sahin K; Isik A
    Inflammation; 2012 Jun; 35(3):810-7. PubMed ID: 21882074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil and daclizumab targeting T lymphocytes in bleomycin-induced experimental scleroderma.
    Ozgen M; Koca SS; Dagli AF; Gundogdu B; Ustundag B; Isik A
    Clin Exp Dermatol; 2012 Jan; 37(1):48-54. PubMed ID: 22182434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Protective Effects of Bevacizumab in Bleomycin-Induced Experimental Scleroderma.
    Koca SS; Ozgen M; Dagli AF; Gozel N; Ozercan IH; Isik A
    Adv Clin Exp Med; 2016; 25(2):249-53. PubMed ID: 27627557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-mediated local delivery of pioglitazone attenuates bleomycin-induced skin fibrosis.
    Kanemaru M; Asai J; Jo JI; Arita T; Kawai-Ohnishi M; Tsutsumi M; Wada M; Tabata Y; Katoh N
    J Dermatol Sci; 2019 Jan; 93(1):41-49. PubMed ID: 30655107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of etanercept in bleomycin-induced experimental scleroderma.
    Koca SS; Isik A; Ozercan IH; Ustundag B; Evren B; Metin K
    Rheumatology (Oxford); 2008 Feb; 47(2):172-5. PubMed ID: 18174229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse model of dermal fibrosis induced by one-time injection of bleomycin-poly(L-lactic acid) microspheres.
    Shibusawa Y; Negishi I; Tabata Y; Ishikawa O
    Rheumatology (Oxford); 2008 Apr; 47(4):454-7. PubMed ID: 18316335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paricalcitol Inhibits Wnt/β-Catenin Signaling Pathway and Ameliorates Dermal Fibrosis in Bleomycin Induced Scleroderma Model.
    Gözel N; Duran F; Yildirim A; Yolbaş S; Önalan E; Özercan İH; Koca SS
    Arch Rheumatol; 2018 Sep; 33(3):288-294. PubMed ID: 30632522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis.
    Karatas A; Celik C; Oz B; Akar ZA; Etem EO; Dagli AF; Koca SS
    Int J Rheum Dis; 2021 Jun; 24(6):795-802. PubMed ID: 33835703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of scleroderma.
    Zhou CF; Yu JF; Zhang JX; Jiang T; Xu SH; Yu QY; Zhu QX
    Clin Exp Dermatol; 2013 Jun; 38(4):403-9. PubMed ID: 23517443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of alpha-lipoic acid on bleomycin-induced skin fibrosis through the repression of NADPH Oxidase 4 and TGF-β1/Smad3 signaling pathways.
    Kocak A; Ural C; Harmanci D; Oktan MA; Afagh A; Sarioglu S; Yilmaz O; Birlik M; Akdogan GG; Cavdar Z
    Hum Exp Toxicol; 2022; 41():9603271211065975. PubMed ID: 35187969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma.
    Wu MH; Yokozeki H; Takagawa S; Yamamoto T; Satoh T; Kaneda Y; Katayama I; Nishioka K
    Gene Ther; 2004 Jan; 11(2):170-80. PubMed ID: 14712301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma.
    Diddi S; Bale S; Pulivendala G; Godugu C
    Inflammopharmacology; 2019 Feb; 27(1):139-149. PubMed ID: 30218238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypical characterization of macrophages in rat bleomycin-induced scleroderma.
    Juniantito V; Izawa T; Yuasa T; Ichikawa C; Yano R; Kuwamura M; Yamate J
    Vet Pathol; 2013 Jan; 50(1):76-85. PubMed ID: 22700848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
    Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A
    J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
    Ohashi T; Yamamoto T
    Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein protects dermal fibrosis in bleomycin-induced experimental scleroderma.
    Koca SS; Dağlı AF; Yolbaş S; Gözel N; Işık A
    Eur J Rheumatol; 2015 Sep; 2(3):99-102. PubMed ID: 27708939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma.
    Nakamura-Wakatsuki T; Oyama N; Yamamoto T
    Exp Dermatol; 2012 Mar; 21(3):189-94. PubMed ID: 22188586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.